APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Genomics & Sequencing Automation Systems

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Genomics & Sequencing Automation Systems Market Outlook and Growth Opportunities 2026

Report ID 174520200412 August 2026206 pages

Choose your research edition.

Industry ResearchGenomics & Sequencing Automation Systems Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Genomics & Sequencing Automation Systems Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Genomics & Sequencing Automation Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genomics & Sequencing Automation Systems Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Genomics & Sequencing Automation Systems Market Analysis and Forecast 2026-2032187 pages · $4,950 USD

Market perspective

The global Genomics & Sequencing Automation Systems market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Genomics & Sequencing Automation Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Genomics & Sequencing Automation Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Genomics & Sequencing Automation Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Genomics & Sequencing Automation Systems market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Genomics & Sequencing Automation Systems market include Agilent Technologies, Revvity, Roche Diagnostics, QIAGEN, Hamilton Company, Tecan, Becton Dickinson, Eppendorf and MGI Tech, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Genomics & Sequencing Automation Systems market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Genomics & Sequencing Automation Systems and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Genomics & Sequencing Automation Systems revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Genomics & Sequencing Automation Systems market.

Genomics & Sequencing Automation Systems Segment by Company

Agilent Technologies

Revvity

Roche Diagnostics

QIAGEN

Hamilton Company

Tecan

Becton Dickinson

Eppendorf

MGI Tech

BGI Genomics

Autobio Diagnostics

Haier Biomedical

DAAN Gene

Illumina

Thermo Fisher Scientific

Danaher

Genomics & Sequencing Automation Systems Segment by Type

Automated Liquid Handling Systems

Automated Nucleic Acid Extraction Systems

NGS Library Preparation Automation Systems

Robotic Sample Processing Workstations

Integrated Genomics Automation Platforms

Sequencing Workflow Automation Systems

Genomics & Sequencing Automation Systems Segment by Application

Pharmaceutical and Biotechnology Companies

Clinical Diagnostic Laboratories

Academic and Research Institutes

Contract Research Organizations (CROs)

Government and Public Health Laboratories

Population Genomics Centers

Genomics & Sequencing Automation Systems Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Genomics & Sequencing Automation Systems status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Genomics & Sequencing Automation Systems key companies, revenue, market share, and recent developments.

3. To split the Genomics & Sequencing Automation Systems breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Genomics & Sequencing Automation Systems market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Genomics & Sequencing Automation Systems significant trends, drivers, influence factors in global and regions.

6. To analyze Genomics & Sequencing Automation Systems competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genomics & Sequencing Automation Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genomics & Sequencing Automation Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genomics & Sequencing Automation Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Genomics & Sequencing Automation Systems industry.

Chapter 3: Detailed analysis of Genomics & Sequencing Automation Systems company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Genomics & Sequencing Automation Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Genomics & Sequencing Automation Systems in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Genomics & Sequencing Automation Systems Industry Trends Table 2. Genomics & Sequencing Automation Systems Industry Drivers Table 3. Genomics & Sequencing Automation Systems Industry Opportunities and Challenges Table 4. Genomics & Sequencing Automation Systems Industry Restraints Table 5. Global Genomics & Sequencing Automation Systems Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Genomics & Sequencing Automation Systems Revenue Share by Company (2021-2026) Table 7. Global Genomics & Sequencing Automation Systems Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Genomics & Sequencing Automation Systems Key Company Manufacturing Base & Headquarters Table 9. Global Genomics & Sequencing Automation Systems Company, Product Type & Application Table 10. Global Genomics & Sequencing Automation Systems Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Genomics & Sequencing Automation Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Automated Liquid Handling Systems Table 15. Significant Companies of Automated Nucleic Acid Extraction Systems Table 16. Significant Companies of NGS Library Preparation Automation Systems Table 17. Significant Companies of Robotic Sample Processing Workstations Table 18. Significant Companies of Integrated Genomics Automation Platforms Table 19. Significant Companies of Sequencing Workflow Automation Systems Table 20. Global Genomics & Sequencing Automation Systems Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Genomics & Sequencing Automation Systems Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Genomics & Sequencing Automation Systems Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Genomics & Sequencing Automation Systems Sales Value Share by Type (2021-2026) Table 24. Global Genomics & Sequencing Automation Systems Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Pharmaceutical and Biotechnology Companies Table 26. Significant Companies of Clinical Diagnostic Laboratories Table 27. Significant Companies of Academic and Research Institutes Table 28. Significant Companies of Contract Research Organizations (CROs) Table 29. Significant Companies of Government and Public Health Laboratories Table 30. Significant Companies of Population Genomics Centers Table 31. Global Genomics & Sequencing Automation Systems Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Genomics & Sequencing Automation Systems Sales Value by Application (2021-2026) & (US$ Million) Table 33. Global Genomics & Sequencing Automation Systems Sales Value by Application (2027-2032) & (US$ Million) Table 34. Global Genomics & Sequencing Automation Systems Sales Value Share by Application (2021-2026) Table 35. Global Genomics & Sequencing Automation Systems Sales Value Share by Application (2027-2032) Table 36. Global Genomics & Sequencing Automation Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Genomics & Sequencing Automation Systems Sales Value by Region (2021-2026) & (US$ Million) Table 38. Global Genomics & Sequencing Automation Systems Sales Value Share by Region (2021-2026) Table 39. Global Genomics & Sequencing Automation Systems Sales Value by Region (2027-2032) & (US$ Million) Table 40. Global Genomics & Sequencing Automation Systems Sales Value Share by Region (2027-2032) Table 41. Global Genomics & Sequencing Automation Systems Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Genomics & Sequencing Automation Systems Sales Value by Country (2021-2026) & (US$ Million) Table 43. Global Genomics & Sequencing Automation Systems Sales Value Market Share by Country (2021-2026) Table 44. Global Genomics & Sequencing Automation Systems Sales Value by Country (2027-2032) & (US$ Million) Table 45. Global Genomics & Sequencing Automation Systems Sales Value Market Share by Country (2027-2032) Table 46. Agilent Technologies Company Information Table 47. Agilent Technologies Business Overview Table 48. Agilent Technologies Genomics & Sequencing Automation Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Agilent Technologies Genomics & Sequencing Automation Systems Product Portfolio Table 50. Agilent Technologies Recent Development Table 51. Revvity Company Information Table 52. Revvity Business Overview Table 53. Revvity Genomics & Sequencing Automation Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Revvity Genomics & Sequencing Automation Systems Product Portfolio Table 55. Revvity Recent Development Table 56. Roche Diagnostics Company Information Table 57. Roche Diagnostics Business Overview Table 58. Roche Diagnostics Genomics & Sequencing Automation Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Roche Diagnostics Genomics & Sequencing Automation Systems Product Portfolio Table 60. Roche Diagnostics Recent Development Table 61. QIAGEN Company Information Table 62. QIAGEN Business Overview Table 63. QIAGEN Genomics & Sequencing Automation Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. QIAGEN Genomics & Sequencing Automation Systems Product Portfolio Table 65. QIAGEN Recent Development Table 66. Hamilton Company Company Information Table 67. Hamilton Company Business Overview Table 68. Hamilton Company Genomics & Sequencing Automation Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Hamilton Company Genomics & Sequencing Automation Systems Product Portfolio Table 70. Hamilton Company Recent Development Table 71. Tecan Company Information Table 72. Tecan Business Overview Table 73. Tecan Genomics & Sequencing Automation Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Tecan Genomics & Sequencing Automation Systems Product Portfolio Table 75. Tecan Recent Development Table 76. Becton Dickinson Company Information Table 77. Becton Dickinson Business Overview Table 78. Becton Dickinson Genomics & Sequencing Automation Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Becton Dickinson Genomics & Sequencing Automation Systems Product Portfolio Table 80. Becton Dickinson Recent Development Table 81. Eppendorf Company Information Table 82. Eppendorf Business Overview Table 83. Eppendorf Genomics & Sequencing Automation Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Eppendorf Genomics & Sequencing Automation Systems Product Portfolio Table 85. Eppendorf Recent Development Table 86. MGI Tech Company Information Table 87. MGI Tech Business Overview Table 88. MGI Tech Genomics & Sequencing Automation Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. MGI Tech Genomics & Sequencing Automation Systems Product Portfolio Table 90. MGI Tech Recent Development Table 91. BGI Genomics Company Information Table 92. BGI Genomics Business Overview Table 93. BGI Genomics Genomics & Sequencing Automation Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. BGI Genomics Genomics & Sequencing Automation Systems Product Portfolio Table 95. BGI Genomics Recent Development Table 96. Autobio Diagnostics Company Information Table 97. Autobio Diagnostics Business Overview Table 98. Autobio Diagnostics Genomics & Sequencing Automation Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Autobio Diagnostics Genomics & Sequencing Automation Systems Product Portfolio Table 100. Autobio Diagnostics Recent Development Table 101. Haier Biomedical Company Information Table 102. Haier Biomedical Business Overview Table 103. Haier Biomedical Genomics & Sequencing Automation Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Haier Biomedical Genomics & Sequencing Automation Systems Product Portfolio Table 105. Haier Biomedical Recent Development Table 106. DAAN Gene Company Information Table 107. DAAN Gene Business Overview Table 108. DAAN Gene Genomics & Sequencing Automation Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. DAAN Gene Genomics & Sequencing Automation Systems Product Portfolio Table 110. DAAN Gene Recent Development Table 111. Illumina Company Information Table 112. Illumina Business Overview Table 113. Illumina Genomics & Sequencing Automation Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Illumina Genomics & Sequencing Automation Systems Product Portfolio Table 115. Illumina Recent Development Table 116. Thermo Fisher Scientific Company Information Table 117. Thermo Fisher Scientific Business Overview Table 118. Thermo Fisher Scientific Genomics & Sequencing Automation Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Thermo Fisher Scientific Genomics & Sequencing Automation Systems Product Portfolio Table 120. Thermo Fisher Scientific Recent Development Table 121. Danaher Company Information Table 122. Danaher Business Overview Table 123. Danaher Genomics & Sequencing Automation Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Danaher Genomics & Sequencing Automation Systems Product Portfolio Table 125. Danaher Recent Development Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Genomics & Sequencing Automation Systems Product Image Figure 2. Global Genomics & Sequencing Automation Systems Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Genomics & Sequencing Automation Systems Market Size (2021-2032) & (US$ Million) Figure 4. Global Genomics & Sequencing Automation Systems Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Automated Liquid Handling Systems Image Figure 8. Automated Nucleic Acid Extraction Systems Image Figure 9. NGS Library Preparation Automation Systems Image Figure 10. Robotic Sample Processing Workstations Image Figure 11. Integrated Genomics Automation Platforms Image Figure 12. Sequencing Workflow Automation Systems Image Figure 13. Global Genomics & Sequencing Automation Systems Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Genomics & Sequencing Automation Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Genomics & Sequencing Automation Systems Sales Value Share by Type (2021-2032) Figure 16. Pharmaceutical and Biotechnology Companies Image Figure 17. Clinical Diagnostic Laboratories Image Figure 18. Academic and Research Institutes Image Figure 19. Contract Research Organizations (CROs) Image Figure 20. Government and Public Health Laboratories Image Figure 21. Population Genomics Centers Image Figure 22. Global Genomics & Sequencing Automation Systems Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Genomics & Sequencing Automation Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Genomics & Sequencing Automation Systems Sales Value Share by Application (2021-2032) Figure 25. Global Genomics & Sequencing Automation Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 26. Global Genomics & Sequencing Automation Systems Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 27. North America Genomics & Sequencing Automation Systems Sales Value (2021-2032) & (US$ Million) Figure 28. North America Genomics & Sequencing Automation Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Europe Genomics & Sequencing Automation Systems Sales Value (2021-2032) & (US$ Million) Figure 30. Europe Genomics & Sequencing Automation Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Asia-Pacific Genomics & Sequencing Automation Systems Sales Value (2021-2032) & (US$ Million) Figure 32. Asia-Pacific Genomics & Sequencing Automation Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 33. South America Genomics & Sequencing Automation Systems Sales Value (2021-2032) & (US$ Million) Figure 34. South America Genomics & Sequencing Automation Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Middle East & Africa Genomics & Sequencing Automation Systems Sales Value (2021-2032) & (US$ Million) Figure 36. Middle East & Africa Genomics & Sequencing Automation Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 37. USA Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. USA Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. USA Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Canada Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Canada Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Canada Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Mexico Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Mexico Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Mexico Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Germany Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Germany Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Germany Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. France Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. France Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. France Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. U.K. Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. U.K. Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. U.K. Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Italy Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Italy Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Italy Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Spain Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Spain Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Spain Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Russia Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Russia Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Russia Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Netherlands Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Netherlands Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Netherlands Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Nordic Countries Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Nordic Countries Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Nordic Countries Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. China Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. China Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. China Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Japan Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Japan Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Japan Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. South Korea Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. South Korea Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. South Korea Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. India Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. India Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. India Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Australia Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Australia Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Australia Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Southeast Asia Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Southeast Asia Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Southeast Asia Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Brazil Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Brazil Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Brazil Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Argentina Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Argentina Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Argentina Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Chile Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Chile Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Chile Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Colombia Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Colombia Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Colombia Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Peru Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Peru Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Peru Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Saudi Arabia Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Israel Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Israel Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Israel Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. UAE Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. UAE Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. UAE Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Turkey Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Turkey Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Turkey Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Iran Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Iran Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Iran Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Egypt Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Egypt Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Egypt Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Years Considered Figure 122. Research Process Figure 123. Key Executives Interviewed

Scope & coverage.

Types
  • Automated Liquid Handling Systems
  • Automated Nucleic Acid Extraction Systems
  • NGS Library Preparation Automation Systems
  • Robotic Sample Processing Workstations
  • Integrated Genomics Automation Platforms
  • Sequencing Workflow Automation Systems
Applications
  • Pharmaceutical and Biotechnology Companies
  • Clinical Diagnostic Laboratories
  • Academic and Research Institutes
  • Contract Research Organizations (CROs)
  • Government and Public Health Laboratories
  • Population Genomics Centers
Companies covered
  • Agilent Technologies
  • Revvity
  • Roche Diagnostics
  • QIAGEN
  • Hamilton Company
  • Tecan
  • Becton Dickinson
  • Eppendorf
  • MGI Tech
  • BGI Genomics
  • Autobio Diagnostics
  • Haier Biomedical
  • DAAN Gene
  • Illumina
  • Thermo Fisher Scientific
  • Danaher

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Genomics & Sequencing Automation Systems Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Genomics & Sequencing Automation Systems Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Genomics & Sequencing Automation Systems Market Dynamics
  1. 2.1 Genomics & Sequencing Automation Systems Industry Trends
  2. 2.2 Genomics & Sequencing Automation Systems Industry Drivers
  3. 2.3 Genomics & Sequencing Automation Systems Industry Opportunities and Challenges
  4. 2.4 Genomics & Sequencing Automation Systems Industry Restraints
3 Genomics & Sequencing Automation Systems Market by Company
  1. 3.1 Global Genomics & Sequencing Automation Systems Company Revenue Ranking in 2025
  2. 3.2 Global Genomics & Sequencing Automation Systems Revenue by Company (2021-2026)
  3. 3.3 Global Genomics & Sequencing Automation Systems Company Ranking (2024-2026)
  4. 3.4 Global Genomics & Sequencing Automation Systems Company Manufacturing Base and Headquarters
  5. 3.5 Global Genomics & Sequencing Automation Systems Company Product Type and Application
  6. 3.6 Global Genomics & Sequencing Automation Systems Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Genomics & Sequencing Automation Systems Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Genomics & Sequencing Automation Systems Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Genomics & Sequencing Automation Systems Market by Type
  1. 4.1 Genomics & Sequencing Automation Systems Type Introduction
  2. 4.1.1 Automated Liquid Handling Systems
  3. 4.1.2 Automated Nucleic Acid Extraction Systems
  4. 4.1.3 NGS Library Preparation Automation Systems
  5. 4.1.4 Robotic Sample Processing Workstations
  6. 4.1.5 Integrated Genomics Automation Platforms
  7. 4.1.6 Sequencing Workflow Automation Systems
  8. 4.2 Global Genomics & Sequencing Automation Systems Sales Value by Type
  9. 4.2.1 Global Genomics & Sequencing Automation Systems Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Genomics & Sequencing Automation Systems Sales Value by Type (2021-2032)
  11. 4.2.3 Global Genomics & Sequencing Automation Systems Sales Value Share by Type (2021-2032)
5 Genomics & Sequencing Automation Systems Market by Application
  1. 5.1 Genomics & Sequencing Automation Systems Application Introduction
  2. 5.1.1 Pharmaceutical and Biotechnology Companies
  3. 5.1.2 Clinical Diagnostic Laboratories
  4. 5.1.3 Academic and Research Institutes
  5. 5.1.4 Contract Research Organizations (CROs)
  6. 5.1.5 Government and Public Health Laboratories
  7. 5.1.6 Population Genomics Centers
  8. 5.2 Global Genomics & Sequencing Automation Systems Sales Value by Application
  9. 5.2.1 Global Genomics & Sequencing Automation Systems Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Genomics & Sequencing Automation Systems Sales Value by Application (2021-2032)
  11. 5.2.3 Global Genomics & Sequencing Automation Systems Sales Value Share by Application (2021-2032)
6 Genomics & Sequencing Automation Systems Regional Value Analysis
  1. 6.1 Global Genomics & Sequencing Automation Systems Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Genomics & Sequencing Automation Systems Sales Value by Region (2021-2032)
  3. 6.2.1 Global Genomics & Sequencing Automation Systems Sales Value by Region: 2021-2026
  4. 6.2.2 Global Genomics & Sequencing Automation Systems Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Genomics & Sequencing Automation Systems Sales Value (2021-2032)
  7. 6.3.2 North America Genomics & Sequencing Automation Systems Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Genomics & Sequencing Automation Systems Sales Value (2021-2032)
  10. 6.4.2 Europe Genomics & Sequencing Automation Systems Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Genomics & Sequencing Automation Systems Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Genomics & Sequencing Automation Systems Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Genomics & Sequencing Automation Systems Sales Value (2021-2032)
  16. 6.6.2 South America Genomics & Sequencing Automation Systems Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Genomics & Sequencing Automation Systems Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Genomics & Sequencing Automation Systems Sales Value Share by Country, 2025 VS 2032
7 Genomics & Sequencing Automation Systems Country-level Value Analysis
  1. 7.1 Global Genomics & Sequencing Automation Systems Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Genomics & Sequencing Automation Systems Sales Value by Country (2021-2032)
  3. 7.2.1 Global Genomics & Sequencing Automation Systems Sales Value by Country (2021-2026)
  4. 7.2.2 Global Genomics & Sequencing Automation Systems Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Genomics & Sequencing Automation Systems Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Genomics & Sequencing Automation Systems Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Genomics & Sequencing Automation Systems Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Agilent Technologies
  2. 8.1.1 Agilent Technologies Company Information
  3. 8.1.2 Agilent Technologies Business Overview
  4. 8.1.3 Agilent Technologies Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Agilent Technologies Genomics & Sequencing Automation Systems Product Portfolio
  6. 8.1.5 Agilent Technologies Recent Developments
  7. 8.2 Revvity
  8. 8.2.1 Revvity Company Information
  9. 8.2.2 Revvity Business Overview
  10. 8.2.3 Revvity Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Revvity Genomics & Sequencing Automation Systems Product Portfolio
  12. 8.2.5 Revvity Recent Developments
  13. 8.3 Roche Diagnostics
  14. 8.3.1 Roche Diagnostics Company Information
  15. 8.3.2 Roche Diagnostics Business Overview
  16. 8.3.3 Roche Diagnostics Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Roche Diagnostics Genomics & Sequencing Automation Systems Product Portfolio
  18. 8.3.5 Roche Diagnostics Recent Developments
  19. 8.4 QIAGEN
  20. 8.4.1 QIAGEN Company Information
  21. 8.4.2 QIAGEN Business Overview
  22. 8.4.3 QIAGEN Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
  23. 8.4.4 QIAGEN Genomics & Sequencing Automation Systems Product Portfolio
  24. 8.4.5 QIAGEN Recent Developments
  25. 8.5 Hamilton Company
  26. 8.5.1 Hamilton Company Company Information
  27. 8.5.2 Hamilton Company Business Overview
  28. 8.5.3 Hamilton Company Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hamilton Company Genomics & Sequencing Automation Systems Product Portfolio
  30. 8.5.5 Hamilton Company Recent Developments
  31. 8.6 Tecan
  32. 8.6.1 Tecan Company Information
  33. 8.6.2 Tecan Business Overview
  34. 8.6.3 Tecan Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Tecan Genomics & Sequencing Automation Systems Product Portfolio
  36. 8.6.5 Tecan Recent Developments
  37. 8.7 Becton Dickinson
  38. 8.7.1 Becton Dickinson Company Information
  39. 8.7.2 Becton Dickinson Business Overview
  40. 8.7.3 Becton Dickinson Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Becton Dickinson Genomics & Sequencing Automation Systems Product Portfolio
  42. 8.7.5 Becton Dickinson Recent Developments
  43. 8.8 Eppendorf
  44. 8.8.1 Eppendorf Company Information
  45. 8.8.2 Eppendorf Business Overview
  46. 8.8.3 Eppendorf Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Eppendorf Genomics & Sequencing Automation Systems Product Portfolio
  48. 8.8.5 Eppendorf Recent Developments
  49. 8.9 MGI Tech
  50. 8.9.1 MGI Tech Company Information
  51. 8.9.2 MGI Tech Business Overview
  52. 8.9.3 MGI Tech Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
  53. 8.9.4 MGI Tech Genomics & Sequencing Automation Systems Product Portfolio
  54. 8.9.5 MGI Tech Recent Developments
  55. 8.10 BGI Genomics
  56. 8.10.1 BGI Genomics Company Information
  57. 8.10.2 BGI Genomics Business Overview
  58. 8.10.3 BGI Genomics Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
  59. 8.10.4 BGI Genomics Genomics & Sequencing Automation Systems Product Portfolio
  60. 8.10.5 BGI Genomics Recent Developments
  61. 8.11 Autobio Diagnostics
  62. 8.11.1 Autobio Diagnostics Company Information
  63. 8.11.2 Autobio Diagnostics Business Overview
  64. 8.11.3 Autobio Diagnostics Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Autobio Diagnostics Genomics & Sequencing Automation Systems Product Portfolio
  66. 8.11.5 Autobio Diagnostics Recent Developments
  67. 8.12 Haier Biomedical
  68. 8.12.1 Haier Biomedical Company Information
  69. 8.12.2 Haier Biomedical Business Overview
  70. 8.12.3 Haier Biomedical Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Haier Biomedical Genomics & Sequencing Automation Systems Product Portfolio
  72. 8.12.5 Haier Biomedical Recent Developments
  73. 8.13 DAAN Gene
  74. 8.13.1 DAAN Gene Company Information
  75. 8.13.2 DAAN Gene Business Overview
  76. 8.13.3 DAAN Gene Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
  77. 8.13.4 DAAN Gene Genomics & Sequencing Automation Systems Product Portfolio
  78. 8.13.5 DAAN Gene Recent Developments
  79. 8.14 Illumina
  80. 8.14.1 Illumina Company Information
  81. 8.14.2 Illumina Business Overview
  82. 8.14.3 Illumina Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Illumina Genomics & Sequencing Automation Systems Product Portfolio
  84. 8.14.5 Illumina Recent Developments
  85. 8.15 Thermo Fisher Scientific
  86. 8.15.1 Thermo Fisher Scientific Company Information
  87. 8.15.2 Thermo Fisher Scientific Business Overview
  88. 8.15.3 Thermo Fisher Scientific Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Thermo Fisher Scientific Genomics & Sequencing Automation Systems Product Portfolio
  90. 8.15.5 Thermo Fisher Scientific Recent Developments
  91. 8.16 Danaher
  92. 8.16.1 Danaher Company Information
  93. 8.16.2 Danaher Business Overview
  94. 8.16.3 Danaher Genomics & Sequencing Automation Systems Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Danaher Genomics & Sequencing Automation Systems Product Portfolio
  96. 8.16.5 Danaher Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst